Bioquímica y Biología Molecular
Departamento
McMaster University
Hamilton, CanadáPublicaciones en colaboración con investigadores/as de McMaster University (32)
2024
-
Assessment of a fast challenge test with iodinated contrast media in allergic patients with anaphylaxis
Allergo Journal International
-
Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)
Journal of Allergy and Clinical Immunology: In Practice
2023
-
A tribute to our friend and colleague Professor Richard M. Epand
Chemistry and Physics of Lipids
-
Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA-MeDALL hypothesis
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 5, pp. 1169-1203
2022
-
Cigarette smoke augments CSF3 expression in neutrophils to compromise alveolar-capillary barrier function during influenza infection
European Respiratory Journal, Vol. 60, Núm. 2
-
Type I interferon regulates proteolysis by macrophages to prevent immunopathology following viral infection
PLoS Pathogens, Vol. 18, Núm. 5
2021
-
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
Clinical and Translational Allergy, Vol. 11, Núm. 4
-
EAACI Biologicals Guidelines—Recommendations for severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 1, pp. 14-44
-
Interrupting reactivation of immunologic memory diverts the allergic response and prevents anaphylaxis
Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 4, pp. 1381-1392
-
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 76, Núm. 10, pp. 2952-2964
-
Oral Immunotherapy for Food-Allergic Children: A Pro-Con Debate
Frontiers in Immunology, Vol. 12
2020
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068
-
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives—A report of the European Academy of Allergy and Clinical Immunology (EAACI)
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 10, pp. 2445-2476
-
Microbial Regulation of Enteric Eosinophils and Its Impact on Tissue Remodeling and Th2 Immunity
Frontiers in Immunology, Vol. 11
2019
-
IgG1 + B-cell immunity predates IgE responses in epicutaneous sensitization to foods
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 74, Núm. 1, pp. 165-175
-
Human BCR analysis of single-sorted, putative IgE+ memory B cells in food allergy
Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 1, pp. 336-339.e6
-
IL-17 Production by γδ+ T Cells Is Critical for Inducing Th17 Responses in the Female Genital Tract and Regulated by Estradiol and Microbiota
ImmunoHorizons, Vol. 3, Núm. 7, pp. 317-330
-
Kaiso-induced intestinal inflammation is preceded by diminished E-cadherin expression and intestinal integrity
PLoS ONE, Vol. 14, Núm. 6